SPOTLIGHT -
Sam Klempner, MD, Looks at Broad Use of ctDNA in Oncology
Sam Klempner, MD, spoke about how clinicians exploring use of ctDNA in gastrointestinal cancers may inform their research with results from other tumor types.
Sam Klempner, MD, Talks ctDNA for Nonmetastatic Gastric and Esophageal Cancers
Sam Klempner, MD, spoke about clinical management and ctDNA for gastrointestinal cancers.
Sam Klempner, MD, Discusses Minimal Residual Disease in Gastrointestinal Cancers
Sam Klempner, MD, spoke about the importance of expanding minimal residual disease platforms for patients with gastrointestinal cancers.
Sam Klempner, MD, Reviews ctDNA Role in Gastroesophageal Cancers
Sam Klempner, MD, spoke about utilizing ctDNA the treat nonmetastatic gastroesophageal cancers at 2022 IGCC.
